Labcorp Holdings Inc. (NYSE: LH), a leading global provider of comprehensive laboratory services, announced today that the company will present at the Jefferies Global Healthcare Conference in 2026. The conference is scheduled for June 3 in New York, with the company's presentation set to begin at 12:15 p.m. Eastern Time.
Labcorp is a global laboratory services giant with operations in approximately 100 countries and nearly 71,000 employees, conducting hundreds of millions of tests annually for patients worldwide. In 2025, the company supported over 85% of new drugs and therapies approved by the FDA. Its business encompasses two main segments: diagnostics and biopharmaceutical laboratory services, with a focus on four core therapeutic areas: oncology, women's health, autoimmune diseases, and neuroscience.
According to the company's first-quarter 2026 financial results, Labcorp delivered strong performance. Total revenue reached $3.54 billion, a year-over-year increase of 5.8%. Adjusted earnings per share were $4.25, up 10.6% year-over-year. Operating income grew 16.8% to $380.8 million. Based on these results, the company raised its full-year corporate revenue growth guidance to a range of 5.0% to 6.1% and increased its adjusted earnings per share guidance to between $17.70 and $18.35.
Strategically, the company recently announced an expanded partnership with Epic to make its full test menu available to hospitals and health systems via Epic's Aura platform, aiming to streamline laboratory integration and enhance access to diagnostic innovation. Labcorp has also partnered with Illumina to expand the application of advanced genomic testing in oncology.
The conference presentation will be webcast live, accessible to investors through the Labcorp Investor Relations website. A replay will be available approximately 24 hours after the event and will be accessible for 90 days.
Comments